Mangalam Drugs and Organics

Mangalam Drugs & Organics Limited is an Indian company primarily engaged in the manufacturing and sale of active pharmaceutical ingredients (APIs) and intermediates. Their product portfolio is extensive and caters to a wide range of pharmaceutical applications.

A significant portion of their API business focuses on producing key components for various medications. This includes antivirals like acyclovir and efavirenz, antimalarials such as artemether and chloroquine phosphate, and other drugs used to treat diverse conditions. The specific APIs they produce are numerous and cover a broad therapeutic spectrum, highlighting their expertise in this area.

Beyond APIs, Mangalam also manufactures and supplies crucial intermediates used in the synthesis of other pharmaceuticals. These intermediates represent a critical step in the production chain, providing the building blocks for complex drug molecules. The company’s capabilities extend to the creation of both simple and complex chemical structures necessary for various pharmaceutical applications.

Furthermore, Mangalam's business extends to the production of specialty chemicals. These encompass diverse chemical compounds with applications beyond pharmaceuticals, demonstrating a broader chemical manufacturing capacity. Their involvement in developing novel compounds like tafenoquine succinate and pretomanid indicates a commitment to research and development within the pharmaceutical and specialty chemical sectors.

In addition to their core business of API, intermediate, and specialty chemical manufacturing, Mangalam also produces organic and inorganic chemicals, as well as heavy chemicals, showcasing a diverse manufacturing capability within the broader chemical industry. Established in 1972 and headquartered in Mumbai, the company's long history reflects a sustained presence and expertise in the Indian chemical manufacturing landscape.